Zai Lab Ltd (ZLAB)

Currency in USD
20.88
+2.51(+13.66%)
Closed·
21.11+0.23(+1.10%)
·

Zai Lab (ZLAB) Earnings Dates & Reports

Latest Release
06/08/2026
EPS / Forecast
-0.05 / -0.60
Revenue / Forecast
106.3M / 104.34M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2026-0.050/-0.600106.30M/104.34M+91.67%+1.88%Free Sign Up
03/2026-0.050/-0.47099.61M/117.97M+89.36%-15.56%Free Sign Up
12/2025-0.050/-0.370127.60M/127.09M+86.49%+0.4%Free Sign Up
09/2025-0.330/-0.250116.10M/150.50M-32%-22.86%Free Sign Up
06/2025-0.370/-0.410109.98M/124.95M+9.76%-11.98%Free Sign Up
03/2025-0.450/-0.460106.49M/113.77M+2.17%-6.4%Free Sign Up
12/2024-0.080/-0.730109.07M/107.69M+89.04%+1.28%Free Sign Up
09/2024-0.040/-0.770102.30M/103.48M+94.81%-1.14%Free Sign Up
06/2024-0.820/-0.708100.10K/93.16M-15.75%-99.89%Free Sign Up
03/2024-0.050/-0.93087.10M/73.99M+94.62%+17.72%Free Sign Up

All numbers in USD

Zai Lab Ltd Earnings Call Summary for Q2/2026

  • Zai Lab posted Q2 adjusted EPS of -$0.05, beating estimates of -$0.60 by 91.67%; revenue reached $106.3M vs. $104.34M forecast.
  • Net product revenue rose 11% sequentially to $105.8M; company ended quarter with $717.5M cash and maintains commercial profitability.
  • Management expects revenue stabilization in H2 2026 and meaningful growth in 2027, with first U.S. regulatory submission planned for 2027.
  • Zoci ADC advances to global pivotal trials; Phase III data expected at ESMO October 2026 with ~60 patients, targeting 80% response rate.
  • ZL-1503 first-in-human data due H2 2026; ZL-1311 IND submission targeted by year-end; operating expenses to remain stable through 2026.
Last Updated: 06/08/2026, 10:52 pm
Read Full Transcript

FAQ

What Is Zai Lab's Earnings Per Share (TTM)?

The Zai Lab EPS (TTM) is -1.62.

When Is The Next Zai Lab Earnings Date?

Zai Lab will release its next earnings report on 06/08/2026.

What Is Zai Lab’s Revenue Forecasts For Upcoming Quarters?

Zai Lab’s revenue forecast is 110.76M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.